Literature DB >> 4853601

Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.

W J Tilstone, H Dargie, E N Dargie, H G Morgan, A C Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4853601     DOI： 10.1002/cpt1974162322

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  18 in total

1.  Possible protein binding displacement interaction between glibenclamide and metolazone.

Authors:  S George; A McBurney; A Cole
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

Review 3.  Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Authors:  Jozine M ter Maaten; Mattia A E Valente; Kevin Damman; Hans L Hillege; Gerjan Navis; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2015-01-06       Impact factor: 32.419

Review 4.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 5.  The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: a critical appraisal of the evidence.

Authors:  Arduino A Mangoni; Elzbieta A Jarmuzewska
Journal:  Br J Clin Pharmacol       Date:  2018-10-14       Impact factor: 4.335

Review 6.  Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally).

Authors:  Ryuichi Ogawa; Joan M Stachnik; Hirotoshi Echizen
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

7.  Pharmacokinetic study of single- and multiple-dosing with metolazone tablets in healthy Chinese population.

Authors:  Xueqing Li; Rutao Wang; Yang Liu; Yun Liu; Heng Zheng; Yabo Feng; Na Zhao; Hongbin Geng; Wanzhi Zhang; Aidong Wen
Journal:  BMC Pharmacol Toxicol       Date:  2017-11-16       Impact factor: 2.483

Review 8.  Diuretic use in renal disease.

Authors:  Domenic A Sica
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

Review 9.  Pharmacokinetics in patients with cardiac failure.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

10.  Bioavailability of quinidine in congestive heart failure.

Authors:  C T Ueda; B S Dzindzio
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.